Cargando…
Induction of apoptosis in infantile hemangioma endothelial cells by propranolol
Propranolol, a non-selective β-blocker, is emerging as an effective treatment for complicated hemangiomas. The aim of this study was to investigate the molecular mechanism(s) underlying the therapeutic effects of propranolol against hemangiomas, using primary infantile hemangioma endothelial cells (...
Autores principales: | TU, JUN-BO, MA, RUI-ZHAO, DONG, QIANG, JIANG, FEI, HU, XIAO-YI, LI, QUAN-YAN, PATTAR, PARUKJAN, ZHANG, HAO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786814/ https://www.ncbi.nlm.nih.gov/pubmed/24137229 http://dx.doi.org/10.3892/etm.2013.1159 |
Ejemplares similares
-
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013) -
Propranolol in the Treatment of Infantile Hemangiomas
por: Tan, Xin, et al.
Publicado: (2021) -
When to stop propranolol for infantile hemangioma
por: Chang, Lei, et al.
Publicado: (2017) -
Effects of propranolol and isoproterenol on infantile hemangioma endothelial cells in vitro
por: ZHU, YALIN, et al.
Publicado: (2014)